Skip to main content

Rhodes Jennifer J

In the past year, 2 open-market sale filings worth $245.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$245.0K
2 filings
Net
−$245.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Rhodes Jennifer J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACAD Acadia Pharmaceuticals Inc

EVP, CHIEF LEGAL OFFICER, SEC2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 26, 2026 (view filing)Mar 251 dayRhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECSSale−3.84K$21.47−$82.5K−25.4%11.3K after
Feb 10, 2026 (view filing)Feb 91 dayRhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECSSale−6.95K$23.38−$162.5K−47.7%7.61K after

ELTX Elicio Therapeutics, Inc.

See Remarks6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 15, 2021 (view filing)Dec 141 dayRhodes Jennifer JSee RemarksSSale−451$2.42−$1.09K−1.5%30.4K after
Nov 16, 2021 (view filing)Nov 151 dayRhodes Jennifer JSee RemarksSSale−433$4.40−$1.91K−1.4%30.9K after
Oct 15, 2021 (view filing)Oct 141 dayRhodes Jennifer JSee RemarksSSale−430$8.65−$3.72K−1.4%31.3K after
Sep 15, 2021 (view filing)Sep 141 dayRhodes Jennifer JSee RemarksSSale−430$10.64−$4.58K−1.3%31.7K after
Aug 17, 2021 (view filing)Aug 161 dayRhodes Jennifer JSee RemarksSSale−445$10.68−$4.75K−1.4%32.1K after
Jul 22, 2021 (view filing)Jul 211 dayRhodes Jennifer JSee RemarksSSale−432$10.94−$4.73K−1.3%32.6K after